Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Consolidated Net Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹699 Cr₹772 Cr₹781 Cr₹1,212 Cr₹997 Cr

What is the latest Consolidated Net Profit of GLAND PHARMA ?

The latest Consolidated Net Profit ratio of GLAND PHARMA is ₹699 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹699 Cr
Mar2025₹772 Cr
Mar2024₹781 Cr
Mar2023₹1,212 Cr
Mar2022₹997 Cr

How is Consolidated Net Profit of GLAND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹699 Cr
-9.57
Mar2025 ₹772 Cr
-1.10
Mar2024 ₹781 Cr
-35.54
Mar2023 ₹1,212 Cr
21.54
Mar2022 ₹997 Cr -

Compare Consolidated Net Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,402.9 Cr 2.9% 19.7% 45.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,994.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹240,249.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,135.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹114,708.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.9 Cr 0.4% 4.5% -4.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.9%

19.7%

45.1%

SENSEX

-0.8%

0.2%

-6%


You may also like the below Video Courses